arrow_back Back to App

Emergency Production of Medicines and Medical Equipment for Public Health

This act establishes a new office within the Department of Health and Human Services to ensure the availability of prescription drugs, medical devices, and personal protective equipment, especially during pandemics. The office will manufacture these products to prevent shortages and reduce costs for health programs, directly impacting the accessibility and pricing of essential medical supplies for citizens.
Key points
Creation of an Emergency Office of Manufacturing for Public Health to produce drugs, biological products, devices, and personal protective equipment.
Ensuring free provision of COVID-19 related products to federal, state, local, and Native health programs.
Authority to acquire rights to manufacture drugs to ensure availability and reduce prices.
Prohibition on hiring former drug company lobbyists and senior executives of law-breaking companies in the new office.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_728
Sponsor: Rep. Schakowsky, Janice D. [D-IL-9]
Process start date: 2021-02-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Pandemic Emergency Manufacturing Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_728.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-02.

What are the main provisions?

Key points include:

  • Creation of an Emergency Office of Manufacturing for Public Health to produce drugs, biological products, devices, and personal protective equipment.
  • Ensuring free provision of COVID-19 related products to federal, state, local, and Native health programs.
  • Authority to acquire rights to manufacture drugs to ensure availability and reduce prices.
  • Prohibition on hiring former drug company lobbyists and senior executives of law-breaking companies in the new office.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Schakowsky, Janice D. [D-IL-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments